European Archives - Page 352 of 1370 - European Medical Journal

Repurposing COVID-19 Vaccines for Effective Cancer Therapy

A groundbreaking study investigated repurposing the COVID-19 mRNA vaccine for cancer treatment.

Total Body Photography with Body Mapping

In this video, Robyn Siperstein emphasises the importance of high-quality total body photography in modern cosmetic and medical…

J&J’s Martin Price on World Cancer Day 2025 – Part 1

A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.

New Model Predicts Hepatocellular Carcinoma Risk in Patients with Noncirrhotic Hepatitis B

A new model predicts HCC risk in noncirrhotic CHB patients, focusing on HBV DNA levels and other key factors.

New Approach to Treating Depression and Anxiety: Virtual Reality Meditation

Immersive virtual reality meditation significantly reduces depression and anxiety in hospital inpatients, enhancing emotional regulation and well-being.

New Study Links Rheumatoid Arthritis to Increased Prostate Cancer Risk

A new study has found a causal link between rheumatoid arthritis and an increased risk of prostate cancer, highlighting the role of chronic inflammation in cancer development.

Low Oxygen Levels Threaten Male Fertility and Future Generations

New research highlights how sleep apnoea, varicocele, and hypoxia impact male fertility, with potential intergenerational consequences.

Family History of Frequent Polyps Linked to Increased Risk of Colorectal Cancer

Frequent polyp diagnoses in relatives significantly raise the risk of colorectal cancer, particularly for early-onset cases.

Aztreonam-Avibactam Offers Hope Against Resistant Gram-Negative Bacteria

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ventilator-associated pneumonia caused by Gram-negative bacteria.

Probiotic Therapy Boosts Survival and Gut Health in Metastatic Colorectal Cancer

A new study has found that combining probiotics with immune checkpoint inhibitors and chemotherapy significantly improves survival rates, intestinal health, and immune response in patients with metastatic colorectal cancer.